Kura Oncology, Inc. (KURA) stock
KURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.34−0.15 (-2.00%)
Close on Nov 18, 2026Market cap $652.97MP/E –Yield –
Kura Oncology price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Kura Oncology's price to sales ratio was 8.9× on Nov 11, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 8.9× | – |
See a number that looks wrong?